HIGHFDA DRUG

Unique Pharmaceuticals Cetirizine Hydrochloride 10 mg Tablets Recalled Nationwide in 2025

9,936 bottles of Cetirizine Hydrochloride Tablets USP 10 mg were recalled nationwide in the United States. Manufactured by Unique Pharmaceuticals Labs and distributed by Rising Pharma Holdings, the lot carries imprint with the wrong ID. Stop using the product immediately and contact the manufacturer or your healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 12, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brands
Cetirizine Hydrochloride, Rising Pharma Holdings, Unique Pharmaceuticals Labs...
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
INFANTS, CHILDREN, ELDERLY

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Cetirizine Hydrochloride, Rising Pharma Holdings, Unique Pharmaceuticals Labs, JB Chemicals & Pharmaceuticals Ltd
Product type
Cetirizine Hydrochloride Tablets 10 mg
Model numbers
PY925014A, 2028-01-31
UPC codes
16571-402, 16571-402-10, 16571-402-50
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 12, 2025

  2. Reported by FDA DRUG

    October 29, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Tablet/Capsules Imprinted with Wrong ID

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact JB Chemicals and Pharmaceuticals Ltd or your healthcare provider for guidance. Notification method: Letter

About This Product

Cetirizine hydrochloride is an OTC antihistamine used to relieve allergy symptoms. This recall involves a packaging/identification error on 10 mg tablets.

Why This Is Dangerous

Wrong imprint ID can lead to misidentification and dosing errors, potentially resulting in inappropriate use.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The recall affects consumers nationwide who may possess mislabeled cetirizine tablets, creating risk of dosing mistakes and confusion.

Practical Guidance

How to identify if yours is affected

  1. Review bottle label for lot PY925014A and expiration 2028-01-31
  2. Compare imprint details with recall notice

Where to find product info

Recall page and details at the FDA enforcement site linked in the article and/or the enforce_rpt recall page provided above.

What timeline to expect

Not specified in the recall notice

If the manufacturer is unresponsive

  • Contact JB Chemicals & Pharmaceuticals Ltd for guidance
  • Contact Rising Pharma Holdings, Inc. for additional information
  • File a complaint with the FDA if needed

How to prevent similar issues

  • Always verify imprint, NDC, lot number, and expiration date before taking any medication
  • Buy from reputable pharmacies and check packaging for consistency with the labeling
  • Be cautious of imprint changes and report suspicious products to manufacturer or regulator
  • Maintain a copy of the recall notice for future reference

Documentation advice

Keep the bottle packaging, recall notice, purchase records, and any correspondence with the manufacturer or distributor

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Cetirizine Hydrochloride. Manufacturer: Unique Pharmaceuticals Labs, a division of J.B. Chemicals & Pharmaceuticals Ltd., Mumbai, India. Distributor: Rising Pharma Holdings, Inc., East Brunswick, NJ. NDC: 16571-402-10. Lot: PY925014A. Expiration: 2028-01-31. Bottles recalled: 9,936. Sold/distributed: U.S. nationwide. Country of origin: India. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Lot PY925014A
  • Manufacturer: Unique Pharmaceuticals Labs (A Div. of JB Chemicals & Pharmaceuticals Ltd.)
  • Distributor: Rising Pharma Holdings, Inc., East Brunswick, NJ United States nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
INFANTSCHILDRENELDERLYPREGNANTPETS
Injury Types
POISONINGLACERATIONOTHER

Product Details

Model Numbers
PY925014A
2028-01-31
UPC Codes
16571-402
16571-402-10
16571-402-50
Affected States
ALL
Report Date
October 29, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more